BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Update

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totalling 4,700 shares, an increase of 6.8% from the December 15th total of 4,400 shares. Based on an average daily volume of 6,700 shares, the short-interest ratio is presently 0.7 days.

BioNxt Solutions Stock Performance

Shares of BNXTF stock opened at $0.25 on Monday. BioNxt Solutions has a 12-month low of $0.11 and a 12-month high of $0.53. The business’s 50 day moving average is $0.22 and its two-hundred day moving average is $0.20.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.